Moderna CEO says data for Omicron-specific shot likely available in March

Covid-flu joint booster jab possible late 2023: Moderna

Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot.

Moderna CEO says data for Omicron-specific shot likely available in March

"The vaccine is being finished, it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference.

Data for Moderna’s Omicron-specific vaccine will probably be available in March

Moderna is also developing a single vaccine that combines a booster dose against Covid-19 with its experimental flu shot

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.

Moderna CEO says expects to share clinical data on omicron-specific vaccine with regulators in March

Omicron vaccine still in the works